Cargando…
The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma
BACKGROUND: N6-methyladenosine (m6A) RNA modification plays a critical role in various physiological and pathological conditions. However, the role of m6A modification in head and neck squamous cell carcinoma (HNSCC) remains elusive. METHODS: In this study, the expression of m6A demethylases was det...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994291/ https://www.ncbi.nlm.nih.gov/pubmed/35395767 http://dx.doi.org/10.1186/s12943-022-01572-2 |
_version_ | 1784684077884899328 |
---|---|
author | Jin, Shufang Li, Mingyu Chang, Hanyue Wang, Ruijie Zhang, Zhiyuan Zhang, Jianjun He, Yue Ma, Hailong |
author_facet | Jin, Shufang Li, Mingyu Chang, Hanyue Wang, Ruijie Zhang, Zhiyuan Zhang, Jianjun He, Yue Ma, Hailong |
author_sort | Jin, Shufang |
collection | PubMed |
description | BACKGROUND: N6-methyladenosine (m6A) RNA modification plays a critical role in various physiological and pathological conditions. However, the role of m6A modification in head and neck squamous cell carcinoma (HNSCC) remains elusive. METHODS: In this study, the expression of m6A demethylases was detected by HNSCC tissue microarray. m6A-RNA immunoprecipitation (MeRIP) sequencing and RNA sequencing were used to identify downstream targets of ALKBH5. Comprehensive identification of RNA-binding proteins by mass spectrometry (ChIRP-MS) was used to explore the m6A “readers”. Tumor-infiltrating lymphocytes were analyzed in SCC7-bearing xenografts in C3H mice. RESULTS: Here, we demonstrate the downregulation of m6A status and upregulation of two demethylases in HNSCC. Silencing the m6A demethylase alkB homolog 5, RNA demethylase (ALKBH5) suppresses tumor progression in vitro and in vivo. m6A-RNA immunoprecipitation sequencing reveals that ALKBH5 downregulates the m6A modification of DDX58 mRNA. Moreover, RIG-I, encoded by the DDX58 mRNA, reverses the protumorigenic characteristics of ALKBH5. ChIRP-MS demonstrates that HNRNPC binds to the m6A sites of DDX58 mRNA to promote its maturation. ALKBH5 overexpression inhibits RIG-I-mediated IFNα secretion through the IKKε/TBK1/IRF3 pathway. The number of tumor-infiltrating lymphocytes in C3H immunocompetent mice is reduced by ALKBH5 overexpression and restored by IFNα administration. Upregulation of AKLBH5 negatively correlates with RIG-I and IFNα expression in HNSCC patients. CONCLUSIONS: These findings unveil a novel mechanism of immune microenvironment regulation mediated by m6A modification through the ALKBH5/RIG-I/IFNα axis, providing a rationale for therapeutically targeting epitranscriptomic modulators in HNSCC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12943-022-01572-2. |
format | Online Article Text |
id | pubmed-8994291 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-89942912022-04-10 The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma Jin, Shufang Li, Mingyu Chang, Hanyue Wang, Ruijie Zhang, Zhiyuan Zhang, Jianjun He, Yue Ma, Hailong Mol Cancer Research BACKGROUND: N6-methyladenosine (m6A) RNA modification plays a critical role in various physiological and pathological conditions. However, the role of m6A modification in head and neck squamous cell carcinoma (HNSCC) remains elusive. METHODS: In this study, the expression of m6A demethylases was detected by HNSCC tissue microarray. m6A-RNA immunoprecipitation (MeRIP) sequencing and RNA sequencing were used to identify downstream targets of ALKBH5. Comprehensive identification of RNA-binding proteins by mass spectrometry (ChIRP-MS) was used to explore the m6A “readers”. Tumor-infiltrating lymphocytes were analyzed in SCC7-bearing xenografts in C3H mice. RESULTS: Here, we demonstrate the downregulation of m6A status and upregulation of two demethylases in HNSCC. Silencing the m6A demethylase alkB homolog 5, RNA demethylase (ALKBH5) suppresses tumor progression in vitro and in vivo. m6A-RNA immunoprecipitation sequencing reveals that ALKBH5 downregulates the m6A modification of DDX58 mRNA. Moreover, RIG-I, encoded by the DDX58 mRNA, reverses the protumorigenic characteristics of ALKBH5. ChIRP-MS demonstrates that HNRNPC binds to the m6A sites of DDX58 mRNA to promote its maturation. ALKBH5 overexpression inhibits RIG-I-mediated IFNα secretion through the IKKε/TBK1/IRF3 pathway. The number of tumor-infiltrating lymphocytes in C3H immunocompetent mice is reduced by ALKBH5 overexpression and restored by IFNα administration. Upregulation of AKLBH5 negatively correlates with RIG-I and IFNα expression in HNSCC patients. CONCLUSIONS: These findings unveil a novel mechanism of immune microenvironment regulation mediated by m6A modification through the ALKBH5/RIG-I/IFNα axis, providing a rationale for therapeutically targeting epitranscriptomic modulators in HNSCC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12943-022-01572-2. BioMed Central 2022-04-09 /pmc/articles/PMC8994291/ /pubmed/35395767 http://dx.doi.org/10.1186/s12943-022-01572-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Jin, Shufang Li, Mingyu Chang, Hanyue Wang, Ruijie Zhang, Zhiyuan Zhang, Jianjun He, Yue Ma, Hailong The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma |
title | The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma |
title_full | The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma |
title_fullStr | The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma |
title_full_unstemmed | The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma |
title_short | The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma |
title_sort | m6a demethylase alkbh5 promotes tumor progression by inhibiting rig-i expression and interferon alpha production through the ikkε/tbk1/irf3 pathway in head and neck squamous cell carcinoma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994291/ https://www.ncbi.nlm.nih.gov/pubmed/35395767 http://dx.doi.org/10.1186/s12943-022-01572-2 |
work_keys_str_mv | AT jinshufang them6ademethylasealkbh5promotestumorprogressionbyinhibitingrigiexpressionandinterferonalphaproductionthroughtheikketbk1irf3pathwayinheadandnecksquamouscellcarcinoma AT limingyu them6ademethylasealkbh5promotestumorprogressionbyinhibitingrigiexpressionandinterferonalphaproductionthroughtheikketbk1irf3pathwayinheadandnecksquamouscellcarcinoma AT changhanyue them6ademethylasealkbh5promotestumorprogressionbyinhibitingrigiexpressionandinterferonalphaproductionthroughtheikketbk1irf3pathwayinheadandnecksquamouscellcarcinoma AT wangruijie them6ademethylasealkbh5promotestumorprogressionbyinhibitingrigiexpressionandinterferonalphaproductionthroughtheikketbk1irf3pathwayinheadandnecksquamouscellcarcinoma AT zhangzhiyuan them6ademethylasealkbh5promotestumorprogressionbyinhibitingrigiexpressionandinterferonalphaproductionthroughtheikketbk1irf3pathwayinheadandnecksquamouscellcarcinoma AT zhangjianjun them6ademethylasealkbh5promotestumorprogressionbyinhibitingrigiexpressionandinterferonalphaproductionthroughtheikketbk1irf3pathwayinheadandnecksquamouscellcarcinoma AT heyue them6ademethylasealkbh5promotestumorprogressionbyinhibitingrigiexpressionandinterferonalphaproductionthroughtheikketbk1irf3pathwayinheadandnecksquamouscellcarcinoma AT mahailong them6ademethylasealkbh5promotestumorprogressionbyinhibitingrigiexpressionandinterferonalphaproductionthroughtheikketbk1irf3pathwayinheadandnecksquamouscellcarcinoma AT jinshufang m6ademethylasealkbh5promotestumorprogressionbyinhibitingrigiexpressionandinterferonalphaproductionthroughtheikketbk1irf3pathwayinheadandnecksquamouscellcarcinoma AT limingyu m6ademethylasealkbh5promotestumorprogressionbyinhibitingrigiexpressionandinterferonalphaproductionthroughtheikketbk1irf3pathwayinheadandnecksquamouscellcarcinoma AT changhanyue m6ademethylasealkbh5promotestumorprogressionbyinhibitingrigiexpressionandinterferonalphaproductionthroughtheikketbk1irf3pathwayinheadandnecksquamouscellcarcinoma AT wangruijie m6ademethylasealkbh5promotestumorprogressionbyinhibitingrigiexpressionandinterferonalphaproductionthroughtheikketbk1irf3pathwayinheadandnecksquamouscellcarcinoma AT zhangzhiyuan m6ademethylasealkbh5promotestumorprogressionbyinhibitingrigiexpressionandinterferonalphaproductionthroughtheikketbk1irf3pathwayinheadandnecksquamouscellcarcinoma AT zhangjianjun m6ademethylasealkbh5promotestumorprogressionbyinhibitingrigiexpressionandinterferonalphaproductionthroughtheikketbk1irf3pathwayinheadandnecksquamouscellcarcinoma AT heyue m6ademethylasealkbh5promotestumorprogressionbyinhibitingrigiexpressionandinterferonalphaproductionthroughtheikketbk1irf3pathwayinheadandnecksquamouscellcarcinoma AT mahailong m6ademethylasealkbh5promotestumorprogressionbyinhibitingrigiexpressionandinterferonalphaproductionthroughtheikketbk1irf3pathwayinheadandnecksquamouscellcarcinoma |